Press releaseGlobe Newswire
Cardiac Biotech Solutions
CBSC · OTC
$0.0327−$0.0028 (−7.89%)TodayMarket closed ·
No price history for this range.
Latest news
- Press releaseGlobe Newswire
Cardiac Biotech Solutions, Inc. Secures Health Canada License for MyCardia AT Device, Now Branded as CardioHolter AT
- Press releaseGlobe Newswire
CBSC Announces $375,000 Purchase Order and Launch of Recurring Revenue Program with Noventis Medical
- Press releaseGlobe Newswire
Cardiac Biotech Solutions, Inc. (CBSC) Signs Exclusive 5-Year Distribution Agreement with Noventis Medical Covering Costa Rica, Panama, Colombia, and Argentina
- Press releaseACCESS Newswire
CB Scientific, Inc. (CBSC) Announces Corporate Name Change to Cardiac Biotech Solutions, Inc.
- Press releaseACCESS Newswire
CB Scientific Inc. (CBSC) Formally Launches Next Generation MyCardia AT Cardiac Monitor
- Press releaseACCESSWIRE
CB Scientific, Inc. Appoints Trip Thomas as Chief Financial Officer
- Press releaseACCESSWIRE
CB Scientific, Inc. Announces Voluntary Delisting from OTCQB Venture Market
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.